JANE STREET GROUP, LLC - SAREPTA THERAPEUTICS INC ownership

SAREPTA THERAPEUTICS INC's ticker is and the CUSIP is 803607900. A total of 6 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of SAREPTA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$34,602,000
+232.0%
219,000
+172.0%
0.01%
+300.0%
Q1 2024$10,421,530
-57.9%
80,500
-68.6%
0.00%
-66.7%
Q4 2023$24,743,938
+2.9%
256,600
+29.3%
0.01%
-25.0%
Q3 2023$24,050,048
+271.0%
198,400
+250.5%
0.01%
+300.0%
Q2 2023$6,481,832
-82.7%
56,600
-79.2%
0.00%
-86.7%
Q1 2023$37,517,326
+104.0%
272,200
+91.8%
0.02%
+66.7%
Q4 2022$18,387,402
-12.4%
141,900
-25.3%
0.01%0.0%
Q3 2022$20,992,000
+177.3%
189,900
+88.0%
0.01%
+200.0%
Q2 2022$7,571,000101,0000.00%
Other shareholders
SAREPTA THERAPEUTICS INC shareholders Q2 2022
NameSharesValueWeighting ↓
GROUP ONE TRADING, L.P. 297,600$22,415,0000.18%
SIMPLEX TRADING, LLC 660$4,971,0000.01%
IMC-Chicago, LLC 28,700$2,162,0000.01%
JPMORGAN CHASE & CO 74,700$5,626,0000.00%
ADVENT CAPITAL MANAGEMENT /DE/ 263$9,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of SAREPTA THERAPEUTICS INC shareholders